Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05300048
Title Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Faeth Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35429 United States Details
Pacific Cancer Specialists Anaheim California 92801 United States Details
Valkyrie Clinical Trials Los Angeles California 90067 United States Details
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 United States Details
Community Health Network, Inc. Indianapolis Indiana 46250 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55902 United States Details
New Jersey Cancer Care, PA Belleville New Jersey 07109 United States Details
Englewood Health Englewood New Jersey 07631 United States Details
Northwell Health Lake Success New York 11042 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
East Carolina University Greenville North Carolina 27858 United States Details
University of Pennsylvania Health System, Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 United States Details
Avera Cancer Institute Sioux Falls South Dakota 57105 United States Details
Baptist Hospitals of Southeast Texas Beaumont Texas 77701 United States Details
Oncology Consultants, PA Houston Texas 77030 United States Details
Lumi Research Kingwood Texas 77339 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field